Performance of EW Edwards Lifesciences | -3.2% in 12m
Compare EW with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Edwards Lifesciences with its related Sector/Index XLV
Performance Duell EW vs XLV
| TimeFrame | EW | XLV |
|---|---|---|
| 1 Day | 0.22% | 0.25% |
| 1 Week | -1.37% | 0.62% |
| 1 Month | -8.35% | -2.22% |
| 3 Months | -0.98% | -0.46% |
| 6 Months | 27.1% | 11.43% |
| 12 Months | -3.23% | 7.26% |
| YTD | 12.8% | 1.84% |
| Rel. Perf. 1m | -0.64 | |
| Rel. Perf. 3m | 0.71 | |
| Rel. Perf. 6m | 1.62 | |
| Rel. Perf. 12m | -1.03 |
Is Edwards Lifesciences a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Edwards Lifesciences (NYSE:EW) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.86 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EW as of May 2024 is 76.94. This means that EW is currently overvalued and has a potential downside of -9.75% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EW as of May 2024 is 76.94. This means that EW is currently overvalued and has a potential downside of -9.75% (Sold with Premium).
Is EW a buy, sell or hold?
- Strong Buy: 11
- Buy: 4
- Hold: 15
- Sell: 1
- Strong Sell: 1
Values above 0%: EW is performing better - Values below 0%: EW is underperforming
Compare EW with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.97% | -6.79% | 8.64% | -30.35% |
| US NASDAQ 100 | QQQ | -2.41% | -6.85% | 8.22% | -41.40% |
| US Dow Jones Industrial 30 | DIA | -2.54% | -7.25% | 12.49% | -21.23% |
| German DAX 40 | DBXD | -0.48% | -6.28% | 8.84% | -16.38% |
| UK FTSE 100 | ISFU | -3.03% | -11.56% | 12.74% | -12.68% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.88% | -11.98% | 23.90% | 6.55% |
| Hongkong Hang Seng | HSI | -7.13% | -16.41% | 28.31% | 10.64% |
| Japan Nikkei 225 | EXX7 | -3.72% | -3.54% | 13.49% | -23.64% |
| India NIFTY 50 | INDA | -2.15% | -10.38% | 7.68% | -32.34% |
| Brasil Bovespa | EWZ | -3.81% | -9.04% | 22.23% | -27.49% |
EW Edwards Lifesciences vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.49% | -5.21% | 7.77% | -41.50% |
| Consumer Discretionary | XLY | -2.51% | -7.21% | 15.63% | -26.55% |
| Consumer Staples | XLP | -1.75% | -10.16% | 15.08% | -5.11% |
| Energy | XLE | 1.94% | -3.68% | 18.42% | -24.48% |
| Financial | XLF | -0.71% | -5.71% | 6.02% | -32.37% |
| Health Care | XLV | -1.99% | -6.13% | 15.68% | -10.49% |
| Industrial | XLI | -1.46% | -6.53% | 5.24% | -29.18% |
| Materials | XLB | -1.38% | -4.74% | 12.27% | -19.11% |
| Real Estate | XLRE | -2.91% | -4.68% | 19.82% | -8.19% |
| Technology | XLK | -2.73% | -6.02% | 8.73% | -40.97% |
| Utilities | XLU | -4.72% | -13.43% | 14.56% | -7.19% |
| Aerospace & Defense | XAR | -3.85% | -10.00% | 11.54% | -26.69% |
| Biotech | XBI | -9.14% | -7.19% | 1.17% | -11.39% |
| Homebuilder | XHB | -2.82% | -5.21% | -9.23% | -53.24% |
| Retail | XRT | -1.64% | -5.63% | 8.06% | -26.69% |
Does Edwards Lifesciences outperform its market, is EW a Sector Leader?
No, over the last 12 months Edwards Lifesciences (EW) made -3.23%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months EW made -0.98%, while XLV made -0.46%.
No, over the last 12 months Edwards Lifesciences (EW) made -3.23%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months EW made -0.98%, while XLV made -0.46%.
| Period | EW | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -8.35% | -2.22% | -1.56% |
| 3 Months | -0.98% | -0.46% | 3.75% |
| 12 Months | -3.23% | 7.26% | 27.12% |